DK0891553T3 - Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier - Google Patents

Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier

Info

Publication number
DK0891553T3
DK0891553T3 DK97917710T DK97917710T DK0891553T3 DK 0891553 T3 DK0891553 T3 DK 0891553T3 DK 97917710 T DK97917710 T DK 97917710T DK 97917710 T DK97917710 T DK 97917710T DK 0891553 T3 DK0891553 T3 DK 0891553T3
Authority
DK
Denmark
Prior art keywords
encephalopathies
spatiform
humans
spongiform encephalopathies
detecting
Prior art date
Application number
DK97917710T
Other languages
English (en)
Inventor
Gary Hsich
Kimbra Kenney
Clarence J Gibbs
Michael G Harrington
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of DK0891553T3 publication Critical patent/DK0891553T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Noise Elimination (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Paper (AREA)
  • Stereo-Broadcasting Methods (AREA)
  • Air Bags (AREA)
  • Electrical Control Of Ignition Timing (AREA)
DK97917710T 1996-04-05 1997-03-31 Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier DK0891553T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/630,961 US5998149A (en) 1996-04-05 1996-04-05 Method of detecting transmissible spongiform encephalopathies
PCT/US1997/005167 WO1997038315A1 (en) 1996-04-05 1997-03-31 A method of detecting transmissible spongiform encephalopathies

Publications (1)

Publication Number Publication Date
DK0891553T3 true DK0891553T3 (da) 2002-10-07

Family

ID=24529265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97917710T DK0891553T3 (da) 1996-04-05 1997-03-31 Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier

Country Status (10)

Country Link
US (2) US5998149A (da)
EP (1) EP0891553B1 (da)
AT (1) ATE219581T1 (da)
AU (1) AU2596797A (da)
CA (1) CA2250715A1 (da)
DE (1) DE69713498T2 (da)
DK (1) DK0891553T3 (da)
ES (1) ES2179324T3 (da)
PT (1) PT891553E (da)
WO (1) WO1997038315A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2319607A (en) * 1996-11-23 1998-05-27 Electrophoretics International Detection of prion proteins in mononuclear cells
AU5601298A (en) * 1996-12-12 1998-07-03 Neuromark Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms
DE19810721A1 (de) * 1998-03-12 1999-10-14 Werner Mueller Anwendung der 14-3-3 Proteine sowie Verfahren zur schnellen Bestimmung der 14-3-3 Proteine als sensitive Biomarker für Pollution u. a. mit polychlorierten Biphenylen (PCBs) und (Xeno)Östrogenen
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
AU4822400A (en) * 1999-05-07 2000-11-21 Ralph S. Daniels Economic and other benefits of refining vegetable oil with potassium hydroxide
WO2001000212A1 (en) * 1999-06-25 2001-01-04 Avicena Group, Inc. Use of creatine or creatine analogs for the prevention and treatment of transmissible spongiform encephalopathies
FR2821431B1 (fr) * 2001-02-28 2003-11-21 Louis Lery Reactif destine au depistage ante-morten d'atnc
DE10131912A1 (de) * 2001-06-06 2002-12-19 Werner E G Mueller Verwendung von 14-3-3 Proteinen und Verfahren zu deren Bestimmung
DE10127500A1 (de) * 2001-06-06 2002-12-12 Simon Kammermeier Verfahren zur Früherkennung von BSE bei Rindern
US20030092090A1 (en) * 2001-11-14 2003-05-15 Kiamars Hajizadeh Rapid prion-detection device, system, and test kit
US7045297B2 (en) * 2001-11-14 2006-05-16 Prion Developmental Laboratories, Inc. Rapid prion-detection assay
US20040248285A1 (en) * 2002-08-09 2004-12-09 Emerge Interactive, Inc. Real-time monitoring of age pigments and factors relating to transmissible spongiform encephalopathies and apparatus
US20050282238A1 (en) * 2003-09-23 2005-12-22 Bowen David J High-sensitivity chemiluminescent ELISA prion detection method
DK2021792T3 (da) * 2006-05-09 2013-05-21 Univ British Columbia Opløste protein-artritmarkører
JP5058711B2 (ja) * 2007-08-17 2012-10-24 サンプラスチックス株式会社 電気泳動解析による表面電位が変化した赤血球の測定方法及びその装置
US7919262B2 (en) * 2007-11-07 2011-04-05 The Uab Research Foundation 14-3-3 proteins for diagnosis of Parkinson's disease
US9079947B2 (en) 2007-11-27 2015-07-14 The University Of British Columbia 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
CA2754741C (en) 2009-03-11 2019-02-12 Augurex Life Sciences Corporation Compositions and methods for characterizing arthritic conditions
AU2012325604B2 (en) 2011-10-21 2017-08-03 Augurex Life Sciences Corp. Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
EP2890807A4 (en) 2012-07-04 2016-08-03 Aptrix Biosystems LLC APTAMERS FOR PRION DIAGNOSTICS AND SYSTEM FOR THE DETECTION OF APTAMER BINDINGS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
WO1991016628A1 (en) * 1990-04-24 1991-10-31 The Regents Of The University Of California Purification, detection and methods of use of protease nexin-2

Also Published As

Publication number Publication date
WO1997038315A1 (en) 1997-10-16
DE69713498D1 (de) 2002-07-25
EP0891553B1 (en) 2002-06-19
ATE219581T1 (de) 2002-07-15
ES2179324T3 (es) 2003-01-16
US6406860B1 (en) 2002-06-18
DE69713498T2 (de) 2003-02-20
US5998149A (en) 1999-12-07
EP0891553A1 (en) 1999-01-20
AU2596797A (en) 1997-10-29
PT891553E (pt) 2002-11-29
CA2250715A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
DK0891553T3 (da) Fremgangsmåde til påvisning af overførbare spogniforme encephalopatier
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
DK0820522T3 (da) Assays og indretninger til detektering af ekstrahepatisk galdeatresi
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
DE69809046D1 (de) Analytische Testvorrichtung und Verfahren zu ihrer Verwendung
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DE69719057D1 (de) Verfahren zur signalverstärkung
DK0901634T3 (da) System til bestemmelse af mindst en parameter i mindst en prøve af en fysiologisk væske samt en kassette
ES2109982T3 (es) Procedimiento y composiciones de ensayo para determinar proteasas en suero, particularmente proteina c activada.
DE60237455D1 (de) Verfahren zur quantifizierung von denaturiertem lipoprotein
WO2003042659A3 (en) Rapid prion-detection assay
DE69626683D1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
DK0696642T3 (da) Fremgangsmåde til påvisning af forstyrrelser i protein C/protein S-systemet
BRPI0607350A2 (pt) método para detecção da presença ou quantidade de uma proteìna erroneamente duplicada em uma amostra e kit
FI20031370A0 (fi) Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
MXPA01006914A (es) Metodos para identificar combinaciones de entidades como terapeuticas.
ATE277353T1 (de) Tau als marker für frühe schäden des zentralen nervensystems
ATE243758T1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
BR0206593A (pt) Métodos para detectar tse e para fixar a proteìna prìon anormal em um substrato, teste para encefalopatias espongiformes transmissìveis, e, tampão
DE60138192D1 (de) Verfahren zur quantifizierung der akt-protein-expression
BR0311709A (pt) Processo capaz de hts e sistema de teste para a determinação da interação entre proteìna reativa com relação ao c e componentes que se ligam à proteìna reativa com relação ao c
WO2001038581A3 (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
EP1281083A4 (en) METHOD FOR DETECTING INFLAMMATION AND IGNITION CONDITIONS
DE69817338D1 (de) Verfahren zum nachweis von autoimmun-pathologien